These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Immunization with dendritic cells infected with mTERT adenovirus vector effectively elicits immunity against mouse H22 hepatoma in vivo]. Jiang N, Wang GS, Li H, Zhang J, Zhang JF, Yi SH, Yi HM, Yang Y, Cai CJ, Lu MQ, Chen GH. Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):405-9. PubMed ID: 19950546 [Abstract] [Full Text] [Related]
4. Immunization of retrovirus-transfected dendritic cells induces specific cytotoxic T lymphocytes for two distinct malarial peptides presented by Kd molecule. Hetttihewa LM. Int Immunopharmacol; 2003 Oct; 3(10-11):1401-11. PubMed ID: 12946436 [Abstract] [Full Text] [Related]
7. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines. Wang J, Saffold S, Cao X, Krauss J, Chen W. J Immunol; 1998 Nov 15; 161(10):5516-24. PubMed ID: 9820528 [Abstract] [Full Text] [Related]
11. Delivery of interferon-alpha transfected dendritic cells into central nervous system tumors enhances the antitumor efficacy of peripheral peptide-based vaccines. Okada H, Tsugawa T, Sato H, Kuwashima N, Gambotto A, Okada K, Dusak JE, Fellows-Mayle WK, Papworth GD, Watkins SC, Chambers WH, Potter DM, Storkus WJ, Pollack IF. Cancer Res; 2004 Aug 15; 64(16):5830-8. PubMed ID: 15313927 [Abstract] [Full Text] [Related]
13. Comparison of DNA- and mRNA-transfected mouse dendritic cells as potential vaccines against the human papillomavirus type 16 associated oncoprotein E7. Dell K, Klein C, Gissmann L. Antivir Ther; 2008 Aug 15; 13(4):495-509. PubMed ID: 18672528 [Abstract] [Full Text] [Related]
15. [Enhanced translational efficacy of internal ribosomal entry site-mediated mRNA in dendritic cells contributes to efficient induction of antitumor immunity]. Tan XH, Wan YH. Zhonghua Yi Xue Za Zhi; 2007 Feb 06; 87(6):399-403. PubMed ID: 17456382 [Abstract] [Full Text] [Related]
16. A TLR9 agonist enhances therapeutic effects of telomerase genetic vaccine. Conforti A, Cipriani B, Peruzzi D, Dharmapuri S, Kandimalla ER, Agrawal S, Mori F, Ciliberto G, La Monica N, Aurisicchio L. Vaccine; 2010 Apr 30; 28(20):3522-30. PubMed ID: 20332048 [Abstract] [Full Text] [Related]
17. Preventive vaccination with telomerase controls tumor growth in genetically engineered and carcinogen-induced mouse models of cancer. Mennuni C, Ugel S, Mori F, Cipriani B, Iezzi M, Pannellini T, Lazzaro D, Ciliberto G, La Monica N, Zanovello P, Bronte V, Scarselli E. Cancer Res; 2008 Dec 01; 68(23):9865-74. PubMed ID: 19047167 [Abstract] [Full Text] [Related]